Canary Speech, a leader in AI-powered voice biomarker technology, has named Dr. Kang Hsu Jr. as its new Chief Medical Officer. With more than twenty years of experience in clinical care, healthcare operations, and digital health innovation, Dr. Hsu will lead the company’s clinical strategy and work to promote the use of voice biomarker solutions. His responsibilities will include managing clinical projects, supporting product development, and building stronger partnerships with organizations like Mayo Clinic, Microsoft, Samsung, LG NOVA, and major healthcare systems. He will also lead research collaborations to build the scientific and clinical evidence behind voice-based diagnostics. As a spokesperson for Canary Speech, he will help highlight the potential of voice technology in transforming medical care.
Health Technology Insights: NESA Becomes First Inpatient Virtual Care Platform Officially Listed in Epic Toolbox
“Canary Speech is redefining how voice can be used to detect and monitor disease,” said Dr. Hsu. Henry O’Connell, CEO of Canary Speech, added, “We are excited to have Dr. Hsu join our team. His knowledge in informatics, health system strategy, and patient-centered care brings a wealth of experience to Canary Speech. As we expand our ambient voice platform, Dr. Hsu’s insights will be essential in shaping our clinical approaches, validating new applications, and building strategic alliances.”
Health Technology Insights: Reid Health Adopts AI Virtual Care in All Patient Rooms
Dr. Hsu shared his excitement about joining the company, stating, “Canary Speech is redefining how voice can be used to detect and monitor disease, and I’m thrilled to join this visionary team to help accelerate the adoption of solutions that can improve lives on a large scale while reducing the workload on physicians. Voice is one of the most powerful, yet underused, tools in medicine, and Canary Speech’s technology brings that potential to the forefront of care.”
Previously, Dr. Hsu served as Associate Vice President for Acute Medical Informatics at Providence, where he coordinated clinical informatics, pharmacy, genomics, research, and laboratory efforts across the entire care journey. He is a board-certified internist and clinical informaticist with senior leadership experience at Providence, St. Joseph Health, and MEDITECH. Dr. Hsu received his medical degree from the Albert Einstein College of Medicine and completed his internal medicine residency at Harbor-UCLA Medical Center. He is fluent in Mandarin and medical Spanish and continues to provide hospice and inpatient care.
This appointment reflects Canary Speech’s commitment to transforming healthcare through real-time, voice-enabled technology that supports early diagnosis, remote monitoring, and proactive interventions.
Health Technology Insights: Kexing Biopharm Enters Strategic Partnership with IQVIA to Accelerate Global Expansion
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
